Debt repayment of ~₹140 crore per year
Management committed to repaying approximately ₹140 crore each year for the next three years, with potential prepayment.
INDOCOREMEDIES / guidance tracker
Keep management guidance in view.
Indoco Remedies · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
other
No major capex planned for next two years
Management stated no major capital expenditure is planned for the next two years, focusing on cash flow improvement.
International business growth to continue
Management expects continued traction in international markets, with US liquid oral launches and European contract manufacturing scaling up.
Warren Remedies API turnaround in 1-2 quarters
Management expects Warren Remedies' API business to improve once regulatory approvals and validations are completed, likely in a couple of quarters.